BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-12

557 industry Phase 2/3 trial readout(s) and 4 FDA decision event(s). Active trials only; estimated dates often slip.

← 2026-11 | 2027-01 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-12-12PDUFA date (company-disclosed)pendingANAPTYSBIO, INC ANABimsidolimabPDUFA Dec. 12, 2026 - ANAPTYSBIO, INC (imsidolimab)
2026-12-12PDUFA date (company-disclosed)pendingVanda Pharmaceuticals Inc. VNDAimsidolimabPDUFA December 12, 2026 - Vanda Pharmaceuticals Inc. (imsidolimab)
2026-12-22PDUFA date (company-disclosed)pendingMineralys Therapeutics, Inc. MLYSlorundrostatPDUFA December 22, 2026 - Mineralys Therapeutics, Inc. (lorundrostat)
2026-12-27PDUFA date (company-disclosed)pendingPraxis Precision Medicines, Inc. PRAXulixacaltamidePDUFA December 27, 2026 - Praxis Precision Medicines, Inc. (ulixacaltamide)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P2ItalfarmacoNCT01761968 Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative NeoplasmsChronic Myeloproliferative Neoplasmsactive not recruiting90
2026-12 est.P2Karyopharm Therapeutics Inc KPTIQNCT02227251 Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Diffuse Large B-cell Lymphomaactive not recruiting244
2026-12 est.P2SynerGene Therapeutics, Inc.NCT02340117 Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic CancerMetastatic Pancreatic Canceractive not recruiting28
2026-12 est.P3Supernus Pharmaceuticals, Inc. SUPNNCT02736656 Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)Attention-Deficit/Hyperactivity Disorderactive not recruiting1400
2026-12 est.P1/P2Cancer Vaccines LimitedNCT03096093 Investigation of a Therapeutic Vaccine (ACIT-1) in CancerCancer; Neoplasmsactive not recruiting34
2026-12 est.P2CivaTech OncologyNCT03290534 Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®Lung Cancer; Lung Cancer Stage I; Lung Cancer Stage IIrecruiting40
2026-12 est.P2Corcept Therapeutics CORTNCT03604198 Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeCushing Syndromeactive not recruiting125
2026-12 est.P3United Therapeutics UTHRNCT03683186 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPAH; Pulmonary Hypertension; Pulmonary Arterial Hypertension; Hypertension; Connective Tissue Diseasenrolling by invitation1000
2026-12 est.P3Tasly Pharmaceuticals, Inc.NCT03789552 Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable AnginaChronic Stable Angina Pectorisrecruiting765
2026-12 est.P2Theralase® Technologies Inc. TLTFFNCT03945162 Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") PatientsNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGrecruiting90
2026-12 est.P1/P2Iperboreal Pharma SrlNCT03994874 Peritoneal Ultrafiltration in Cardio Renal Syndrome.Congestive Heart Failurerecruiting84
2026-12 est.P2BioRestorative Therapies BRTXNCT04042844 A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)Lumbar Disc Diseaserecruiting99
2026-12 est.P1/P2Phoenix Molecular DesignsNCT04115306 Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast CancerMetastatic Breast Canceractive not recruiting61
2026-12 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04344158 A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma (HCC)active not recruiting648
2026-12 est.P3Inmunotek S.L.NCT04435990 Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesRhinitis, Allergic; Rhinoconjunctivitis; Asthma, Allergicrecruiting150
2026-12 est.P2/P3Karyopharm Therapeutics Inc KPTIQNCT04442022 A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Diffuse Large B-cell Lymphomaactive not recruiting501
2026-12 est.P1/P2Sapience TherapeuticsNCT04478279 A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsGlioblastoma; Melanoma Stage IV; Breast Cancer; Prostate Cancer; Glioblastoma Multiforme; GBM; Brainactive not recruiting125
2026-12 est.P1/P2GE HealthcareNCT04604782 A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric PatientsMyocardial Ischemia; Coronary Artery Diseaserecruiting54
2026-12 est.P3Gilead Sciences GILDNCT04639986 Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)Metastatic Breast Canceractive not recruiting331
2026-12 est.P2/P3AbbVie ABBVNCT04704921 Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMDAMD; nAMD; Wet Age-related Macular Degeneration; wAMD; Wet AMD; CNV; Neovascular AMD; Neovascular Agactive not recruiting671
2026-12 est.P2Ambrx, Inc.NCT04829604 ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)HER2 Positive Metastatic Breast Canceractive not recruiting72
2026-12 est.P3Allist Pharmaceuticals, Inc.NCT04853342 To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small CNon-small Cell Lung Carcinomarecruiting318
2026-12 est.P3Kedrion S.p.A.NCT04944979 Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)Primary Immunodeficiency Diseaseactive not recruiting30
2026-12 est.P3GC Cell CorporationNCT04969731 Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic CancerPancreatic Ductal Adenocarcinomarecruiting408
2026-12 est.P2UBP Greater China (Shanghai) Co., LtdNCT04985890 A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral ReservoirHIV-1-infectionnot yet recruiting20
2026-12 est.P2Zenith EpigeneticsNCT04986423 ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancerrecruiting200
2026-12 est.P1/P23D Medicines (Sichuan) Co., Ltd.NCT05024214 Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid TumorsSolid Tumors; Non-small Cell Lung Cancer; Renal Cell Carcinoma; Hepatocellular Carcinomarecruiting170
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05054439 A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCCHead and Neck Squamous Cell Carcinomaactive not recruiting45
2026-12 est.P2/P3DiaMedica Therapeutics Inc DMACNCT05065216 Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)Acute Stroke; Ischemic Stroke; Strokerecruiting728
2026-12 est.P23D Medicines (Sichuan) Co., Ltd.NCT05112991 Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial CancerAdvanced Endometrial Cancerrecruiting108
2026-12 est.P2Sunshine Lake Pharma Co., Ltd. SBFMNCT05139719 A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung DisProgressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)recruiting110
2026-12 est.P2Ascentage Pharma Group Inc. AAPGNCT05147467 Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLLChronic Lymphocytic Leukemia; Small Lymphocytic Lymphomarecruiting75
2026-12 est.P1/P2Nanjing Leads Biolabs Co.,LtdNCT05170958 A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant TumorsAdvanced Solid Tumorrecruiting396
2026-12 est.P2Lion TCR Pte. Ltd.NCT05195294 Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCCHepatocellular Carcinoma; Liver Cancer, Adult; Liver Cell Carcinomanot yet recruiting55
2026-12 est.P1/P2Rottapharm BiotechNCT05205330 Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI CancersRefractory Metastatic Colorectal Cancer; Solid Tumor; Metastatic Microsatellite-stable Colorectal Caactive not recruiting107
2026-12 est.P1/P2Denali Therapeutics Inc. DNLINCT05262023 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal DemeFrontotemporal Dementiaactive not recruiting85
2026-12 est.P23D MedicinesNCT05265052 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer PainCancer Painnot yet recruiting177
2026-12 est.P3Genelux Corporation GNLXNCT05281471 Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/RefractoryPlatinum-resistant Ovarian Cancer; Platinum-refractory Ovarian Cancer; Fallopian Tube Cancer; Primarrecruiting186
2026-12 est.P1/P2Keymed Biosciences Co.LtdNCT05299424 A Study of CM336 in Patients With Relapsed or Refractory Multiple MyelomaMultiple Myelomarecruiting48
2026-12 est.P2Aveta Biomics, Inc.NCT05312710 Safety and Efficacy of APG-157 in Head and Neck CancerHead and Neck Cancer; Squamous Cell Carcinoma of Oral Cavity; Squamous Cell Carcinoma of the Oropharactive not recruiting24
2026-12 est.P2TolerogenixX GmbHNCT05365672 Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney TransplantationKidney Transplantationrecruiting126
2026-12 est.P1/P2Stemline Therapeutics, Inc.NCT05386108 Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerBreast Neoplasms; Brain Neoplasms; Neoplasms by Site; Neoplasms; Breast Diseases; Central Nervous Syrecruiting73
2026-12 est.P3Ionis Pharmaceuticals, Inc. IONSNCT05392114 A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)Hereditary Angioedemaactive not recruiting154
2026-12 est.P2Kite, A Gilead CompanyNCT05396885 Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)Multiple Myelomaactive not recruiting136
2026-12 est.P3Suven Life Sciences LimitedNCT05397639 Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypeAgitation; Alzheimer's Type Dementiaactive not recruiting375
2026-12 est.P1/P2SynDevRx, Inc.NCT05455619 Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast CancerHR+/HER2-negative Breast Cancer; Metastatic Breast Cancerrecruiting52
2026-12 est.P2Lantern Pharma Inc. LTRNNCT05456256 A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaAdenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lungrecruiting90
2026-12 est.P1/P2Step Pharma, SASNCT05463263 A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell LymphomasLymphoma, B-Cell; Lymphoma, T-Cellrecruiting180
2026-12 est.P1/P2AP Biosciences Inc.NCT05473156 A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion Locally Advanced or Metastatic Solid Tumors; Non Small Cell Lung Cancer (NSCLC); Head and Neck Squamrecruiting168
2026-12 est.P1/P2Dren BioNCT05475925 A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasLGLL - Large Granular Lymphocytic Leukemia; Primary Cutaneous Gamma-Delta T-Cell Lymphoma; Primary Crecruiting200
2026-12 est.P3RayzeBio, Inc.NCT05477576 Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyGEP-NET; Gastroenteropancreatic Neuroendocrine Tumor; Gastroenteropancreatic Neuroendocrine Tumor Diactive not recruiting343
2026-12 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT05482568 A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung CancerAdvanced Non-small Cell Lung Cancerrecruiting324
2026-12 est.P3Madrigal Pharmaceuticals, Inc. MDGLNCT05500222 A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)NASH; Cirrhosis, Liveractive not recruiting845
2026-12 est.P1/P2Monte Rosa Therapeutics, Inc GLUENCT05546268 Study of Oral MRT-2359 in Selected Cancer PatientsNSCLC; SCLC; High Grade Neuroendocrine Cancer; DLBCL; L-MYC and N-MYC Amplified Solid Tumors; NSCLC active not recruiting174
2026-12 est.P2Sinew Pharma Inc.NCT05557448 To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen OverdoseHepatitisrecruiting24
2026-12 est.P1/P2Eupraxia Pharmaceuticals Inc. EPRXNCT05608681 A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).Eosinophilic Esophagitisrecruiting117
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05623982 A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNon-hodgkin's Lymphomarecruiting40
2026-12 est.P1/P2OriCell Therapeutics Co., Ltd.NCT05652920 Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCCHepatocellular Carcinomarecruiting105
2026-12 est.P3Mabscale, LLCNCT05654454 A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung CancerNon-Small Cell Lung Cancerrecruiting620
2026-12 est.P1/P2In8bio Inc. INABNCT05664243 A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance TemozolomGlioblastomaactive not recruiting4
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05668858 A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and Neckactive not recruiting70
2026-12 est.P1/P2AkesoNCT05689853 Study of AK119 Combined With AK112 in Patients With Advanced Solid TumorsSolid Tumor, Adultrecruiting87
2026-12 est.P2Amydis Inc.NCT05709314 A Study of AMDX-2011P in Participants With CAACerebral Amyloid Angiopathyrecruiting25
2026-12 est.P2Taiho Oncology, Inc.NCT05727176 Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or RearrangementAdvanced Cholangiocarcinoma; FGFR2 Fusions; Gene Rearrangementrecruiting120
2026-12 est.P1/P2A2 Biotherapeutics Inc.NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 ExpressionSolid Tumor, Adult; Solid Tumor; Pancreatic Cancer; Pancreatic Neoplasms; Pancreas Cancer; Non Smallactive not recruiting160
2026-12 est.P2Zucara Therapeutics Inc.NCT05762107 A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesType 1 Diabetes Mellitus With Hypoglycemiarecruiting186
2026-12 est.P3Cook MyoSiteNCT05776277 Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric InjuryFecal Incontinenceactive not recruiting200
2026-12 est.P2/P3ReAlta Life Sciences, Inc.NCT05778188 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy UndHypoxic-Ischemic Encephalopathyrecruiting173
2026-12 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05780567 Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancBreast Canceractive not recruiting1946
2026-12 est.P1/P2TiumBio Co., Ltd.NCT05784688 Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid TumorsSolid Tumor; Biliary Tract Cancer; Head and Neck Squamous Cell Carcinoma; Colorectal Cancerrecruiting140
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05785039 A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System TumorsUrinary System Tumor; Solid Tumorrecruiting76
2026-12 est.P1/P2Tern Therapeutics, LLCNCT05791864 A Registrational Study of TTX-381 to Treat Vision Loss in CLN2 DiseaseNeuronal Ceroid Lipofuscinosis Type 2recruiting26
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05803018 A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological MalignanciesGynecological Malignant Tumor; Solid Tumorrecruiting38
2026-12 est.P1/P2GeneCradle IncNCT05824169 Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 PatientsSpinal Muscular Atrophyrecruiting18
2026-12 est.P2Protara Therapeutics TARANCT05871970 Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of AgeLymphatic Malformationrecruiting38
2026-12 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT05884255 An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.Advanced Gastroenteropancreatic Neuroendocrine Tumorrecruiting220
2026-12 est.P1/P2Beam Therapeutics Inc. BEAMNCT05885464 A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LLLymphoblastic Lymphoma; T-Cell Lymphoblastic Leukemia/Lymphoma; Lymphoblastic Leukemiaactive not recruiting5
2026-12 est.P1/P2Guangzhou Gloria Biosciences Co., Ltd.NCT05909436 Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid TumorsSolid Tumorrecruiting107
2026-12 est.P2Alto Neuroscience ANRONCT05922878 Study of ALTO-300 in MDDMajor Depressive Disorderrecruiting325
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05924841 A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung CancerSmall Cell Lung Cancerrecruiting100
2026-12 est.P1/P2BioCardia, Inc. BCDANCT05925608 Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem CellsHeart Failure, Systolicactive not recruiting39
2026-12 est.P3TransThera Sciences (Nanjing), Inc.NCT05948475 Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in CholangiocarcinomaCholangiocarcinomaactive not recruiting200
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05949606 A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung CancerNon-small Cell Lung Canceractive not recruiting95
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05956587 A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumNon-small Cell Lung Cancer; Nasopharyngeal Carcinomarecruiting121
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05965856 A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid TumorsUrothelial Carcinoma; Solid Tumorrecruiting52
2026-12 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05987358 A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.Biliary Carcinomaactive not recruiting165
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT05990803 A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological MalignanciesCervical Cancerrecruiting130
2026-12 est.P2Aadi Bioscience, Inc.NCT05997017 Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerEndometrial Cancer; Endometrioid Tumor; Cancer; Tumor; Recurrent Endometrial Carcinoma; Endometrioidrecruiting29
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06006169 A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid TumorsHead and Neck Squamous Cell Carcinomarecruiting186
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06008054 A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, CoEsophageal Cancer; Gastric Cancer; Colorectal Cancerrecruiting376
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06031584 A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and GastrointestinaHer2-positive/Low-expression Urinary and Digestive Tract Tumorsrecruiting42
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06042894 A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast CancerBreast Cancerrecruiting58
2026-12 est.P2NS Pharma, Inc.NCT06046222 Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With PolyangiitisEosinophilic Granulomatosis With Polyangiitis; Churg-Strauss Syndromeactive not recruiting45
2026-12 est.P1/P2Institut de Recherches Internationales Servier (I.R.I.S.)NCT06052813 A Study of BN104 in the Treatment of Acute LeukemiaALL, Adult; AML, Adult; Acute Leukaemia; KMT2A Rearrangement; NPM1 Mutation; NUP98 Gene Rearrangemenactive not recruiting66
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06066203 A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological MalignanciesNon-hodgkin's Lymphomarecruiting40
2026-12 est.P2Frantz Viral Therapeutics, LLCNCT06075264 Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)Vulvar Diseases; HPV Infection; Vulvar HSIL; Pre-Cancerous Dysplasia; HPV Disease; VIN, Usual Type; recruiting27
2026-12 est.P2Panafina, Inc.NCT06080789 A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute PancreatitisAcute Pancreatitisrecruiting36
2026-12 est.P1/P2Nexcella Inc.NCT06097832 Study of NXC-201 CAR-T in Patients With Light Chain (AL) AmyloidosisLight Chain (AL) Amyloidosisactive not recruiting45
2026-12 est.P2AbbVie ABBVNCT06107413 Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable MetUnresectable Metastatic Colorectal Canceractive not recruiting280
2026-12 est.P1/P2Lexeo Therapeutics LXEONCT06109181 Gene Therapy for ACM Due to a PKP2 Pathogenic VariantArrhythmogenic Cardiomyopathy; PKP2-ACM; PKP2-ARVCactive not recruiting10
2026-12 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06114511 A Study of BL-M07D1 in Patients With HER2-Overexpressing or HER2-Mutant Locally Advanced or Metastatic Non-Small Cell Lung CancerNon-small Cell Lung Canceractive not recruiting78
2026-12 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06122831 A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)Myelofibrosisrecruiting92
2026-12 est.P2/P3Biohaven Therapeutics Ltd. BHVNNCT06132893 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyFocal Epilepsyactive not recruiting390
2026-12 est.P1/P2Bivision Pharmaceuticals, Inc.NCT06139575 Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate CancerProstate Cancerrecruiting90
2026-12 est.P1/P2Xenothera SASNCT06154291 FIH XON7 in Advanced/Metastatic Solid TumorsAdvanced Solid Tumor; Metastatic Cancerrecruiting255
2026-12 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06202261 A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast CancerMetastatic Breast Cancer; Recurrent Breast Cancer; Advanced Malignanciesrecruiting154
2026-12 est.P3Boryung Pharmaceutical Co., LtdNCT06220773 A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination TherapyEssential Hypertension; Type 2 Diabetes Mellitusrecruiting276
2026-12 est.P2/P3RemeGen Co., Ltd.NCT06221748 DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line TherapGastric Cancer; Gastroesophageal Junction Adenocarcinomarecruiting90
2026-12 est.P1/P2Alyssum TherapeuticsNCT06234098 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, RefraSolid Tumorrecruiting100
2026-12 est.P1/P2Sichuan Huiyu Pharmaceutical Co., LtdNCT06243354 Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS MutationSafety; Tolerability; Efficacyrecruiting257
2026-12 est.P2Eikon Therapeutics EIKNNCT06246110 A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLCNSCLCactive not recruiting70
2026-12 est.P1/P2Songqi GaoNCT06262139 Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer PatientsMRI Scanrecruiting12
2026-12 est.P3Pacira Pharmaceuticals, Inc PCRXNCT06269705 ZILRETTA in Subjects With Shoulder OsteoarthritisGlenohumeral Osteoarthritisactive not recruiting150
2026-12 est.P3Gossamer Bio USA, Inc. GOSSNCT06274801 Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)Pulmonary Arterial Hypertensionrecruiting330
2026-12 est.P1/P2Latticon Antibody Therapeutics, IncNCT06277219 A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)Advanced Solid Tumorrecruiting150
2026-12 est.P2Omeros Corporation OMERNCT06298955 Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuriaactive not recruiting25
2026-12 est.P2Kind Pharmaceuticals LLCNCT06302491 A Study of Safety and Efficiency of AND017 in Patients With β-thalassemiaβ -Thalassemiarecruiting64
2026-12 est.P2Kind Pharmaceuticals LLCNCT06304103 A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic SyndromeMyelodysplastic Syndromesrecruiting63
2026-12 est.P2Zhejiang Haichang Biotech Co., Ltd.NCT06309485 Phase 2 Study of WGI-0301 for Advanced HCCAdvanced Hepatocellular Carcinoma (HCC)recruiting60
2026-12 est.P1/P2Theravectys S.A.NCT06319963 A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal CancerHPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinomarecruiting72
2026-12 est.P2Sound Pharmaceuticals, Incorporated SOGPNCT06340633 SPI-1005 in Adults Receiving Cochlear ImplantHearing Loss; Cochlear Traumarecruiting40
2026-12 est.P2ReAlta Life Sciences, Inc.NCT06343792 Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host DiseaseSteroid Refractory GVHDrecruiting66
2026-12 est.P1/P2Beijing Scitech-Mq Pharmaceuticals LimitedNCT06359860 A Study of ST-1898 for Unresectable or Metastatic MelanomaUnresectable or Metastatic Melanomaactive not recruiting64
2026-12 est.P3OctapharmaNCT06361537 Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of AAcute Hereditary Angio Edemarecruiting124
2026-12 est.P3Sichuan Baili Pharmaceutical Co., Ltd.NCT06382129 A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02)Non-small Cell Lung Canceractive not recruiting698
2026-12 est.P1/P2GeneCradle IncNCT06391736 Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy DrugPompe Disease (Late-onset)recruiting33
2026-12 est.P1/P2858 Therapeutics, Inc.NCT06395519 A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesAdvanced or Metastatic Solid Tumors; Breast Cancer; Ovarian Cancer; Prostate Cancer; Epithelial Ovarrecruiting120
2026-12 est.P2NoNO Inc.NCT06403267 NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular ThrombectomyAcute Ischemic Strokerecruiting600
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06405425 A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial CarcinomaUrothelial Carcinomarecruiting52
2026-12 est.P3Axsome Therapeutics, Inc. AXSMNCT06413433 Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using SolriamfetolBinge-Eating Disorderrecruiting450
2026-12 est.P2NMD Pharma A/SNCT06414954 Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia GravisMyasthenia Gravis; Myasthenia Gravis, MuSKrecruiting84
2026-12 est.P2Highlight TherapeuticsNCT06422936 Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)Basal Cell Carcinomaactive not recruiting50
2026-12 est.P1/P2Georgiamune IncNCT06425926 Safety and Tolerability Study of GIM-531 in Advanced Solid TumorsMelanoma Stage IV; Solid Tumorrecruiting117
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06437509 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung CancerExtensive-stage Small-cell Lung Cancerrecruiting66
2026-12 est.P2Biohaven Therapeutics Ltd. BHVNNCT06443463 Long-term Safety and Tolerability of BHV-7000Focal Epilepsyenrolling by invitation660
2026-12 est.P3Prove pharmNCT06448143 Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric PatientsUreter Injurynot yet recruiting18
2026-12 est.P2Abivax S.A. ABVXNCT06456593 Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseModerately to Severely Active Crohn Diseaserecruiting212
2026-12 est.P3AbbVie ABBVNCT06468228 A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativaactive not recruiting1400
2026-12 est.P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06471205 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast CancerTriple-negative Breast Cancerrecruiting52
2026-12 est.P2Shanghai BDgene Co., Ltd.NCT06474442 A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal KeratitisHerpes Simplex Virus Type I Stromal Keratitisrecruiting40
2026-12 est.P3VIS, Inc.NCT06487897 Phase III Presbyopia Correction Using the VIS Opti-K™ SystemPresbyopiarecruiting75
2026-12 est.P3Sichuan Baili Pharmaceutical Co., Ltd.NCT06500026 A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)Small Cell Lung Canceractive not recruiting722
2026-12 est.P1/P2Meribank Biotech Co., Ltd.NCT06501066 Mesenchymal Stem Cells for Frailty SyndromePathologic Processesactive not recruiting66
2026-12 est.P1/P2SCG Cell Therapy Pte. Ltd.NCT06505551 Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaHPV-Related Squamous Cell Carcinoma; HPV-Related Cervical Squamous Cell Carcinoma; HPV-Related Vulvanot yet recruiting66
2026-12 est.P3Nanjing Chia-tai Tianqing PharmaceuticalNCT06512363 A Study of Ramelteon in Chinese Patients With Chronic InsomniaChronic Insomnianot yet recruiting280
2026-12 est.P2Ryvu Therapeutics SANCT06534437 MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)Non-Hodgkin Lymphoma, B-cellrecruiting178
2026-12 est.P2Dianthus Therapeutics DNTHNCT06537999 A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyMultifocal Motor Neuropathyactive not recruiting46
2026-12 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT06568094 A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerProstate Cancerrecruiting100
2026-12 est.P3Axsome Therapeutics, Inc. AXSMNCT06568367 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)Excessive Sleepiness; Shift-work Disorderrecruiting520
2026-12 est.P3MediWound Ltd MDWDNCT06568627 A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)Venous Leg Ulcer (VLU)recruiting216
2026-12 est.P2Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT06569524 Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)Non-alcoholic Steatohepatitisrecruiting120
2026-12 est.P3Wuxi Cellular Biopharmaceutical Group Ltd.NCT06570291 Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee OsteoarthritisKnee Osteoarthritisrecruiting520
2026-12 est.P2Angitia BiopharmaceuticalsNCT06577935 A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)Postmenopausal Osteoporosisactive not recruiting379
2026-12 est.P2Sunhawk Vision Biotech, Inc.NCT06579287 A Study of SHJ002 Sterile Ophthalmic Solution for Myopia ControlMyopia, Progressiveactive not recruiting140
2026-12 est.P2/P3iCoat Medical ABNCT06582485 A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD KidneysIschemia-reperfusion Injury; Kidney Transplant; Complicationsnot yet recruiting200
2026-12 est.P3Dr. Falk Pharma GmbHNCT06596252 Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEEosinophilic Esophagitisactive not recruiting308
2026-12 est.P1/P2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT06605222 A Trial of SHR-7787 Injection in Patients With Advanced Solid TumorsAdvanced Solid Tumorsrecruiting201
2026-12 est.P2Delcath Systems Inc. DCTHNCT06607458 Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or ApprRefractory Metastatic Colorectal Cancerrecruiting90
2026-12 est.P2Filament Health Corp.NCT06608459 PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility StudyOpioid Use Disordernot yet recruiting10
2026-12 est.P1/P2LaNova Medicines LimitedNCT06650566 Study of LM-299 in Subjects Advanced Malignant TumorsMalignant Tumorsrecruiting108
2026-12 est.P1/P2Ranok Therapeutics (Hangzhou) Co., Ltd.NCT06667544 A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D MutationKRAS G12D Mutationrecruiting152
2026-12 est.P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06671379 A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLCNon-small Cell Lung Canceractive not recruiting498
2026-12 est.P1/P2Technophage, SANCT06677229 Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord InjuryAcute Spinal Cord Injury (SCI)recruiting28
2026-12 est.P1/P2Wuhan Optics Valley Vcanbiopharma Co., Ltd.NCT06677255 A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) TreatmentSteroid-refractory Acute Graft-versus-host Diseasenot yet recruiting149
2026-12 est.P3TR TherapeuticsNCT06707103 Tissue Repair Gel in Venous Leg Ulcers in AU/USVenous Leg Ulcer; Venous Ulcer; Venous Stasis Ulcer; Venous Stasis; Wound Heal; Wound; Venous Insuffrecruiting312
2026-12 est.P2Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.NCT06707883 A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Diseaseactive not recruiting258
2026-12 est.P3Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. SKBBYNCT06711900 A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients WiNon-Small Cell Lung Canceractive not recruiting432
2026-12 est.P2/P3Napo Pharmaceuticals, Inc.NCT06721871 Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)Microvillus Inclusion Disease; Congenital Disorders; Rare Diseasesactive not recruiting6
2026-12 est.P2Shandong New Time Pharmaceutical Co., LTDNCT06722950 Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral NeuropathyColorectal Adenomanot yet recruiting120
2026-12 est.P2Centessa Pharmaceuticals (UK) LimitedNCT06752668 A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaNarcolepsy Type 1; Narcolepsy Type 2; Idiopathic Hypersomniarecruiting248
2026-12 est.P3Qilu Pharmaceutical Co., Ltd.NCT06754644 A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLCNSCLCrecruiting808
2026-12 est.P3AkesoNCT06767527 AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast CancerTriple-Negative Breast Cancer (TNBC)recruiting416
2026-12 est.P3Azidus BrasilNCT06817096 Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and InfluenzaCovid 19; Influenzanot yet recruiting340
2026-12 est.P2Shandong Suncadia Medicine Co., Ltd.NCT06820099 Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and ObesityAdults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesirecruiting225
2026-12 est.P1/P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06840002 A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian CancerOvarian Cancerrecruiting150
2026-12 est.P3Astria Therapeutics, Inc.NCT06842823 A Study of Navenibart in Participants With Hereditary AngioedemaHereditary Angioedema (HAE)active not recruiting157
2026-12 est.P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06844474 A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLCNSCLCrecruiting300
2026-12 est.P2Dogwood Therapeutics Inc. DWTXNCT06848348 Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainChemotherapy Induced Neuropathic Pain; Chemotherapy Induced Pain Neuropathy; Chemotherapy Induced Paactive not recruiting240
2026-12 est.P2Cardiac SuccessNCT06851949 Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart FailureHeart Failure With Reduced Ejection Fractionrecruiting20
2026-12 est.P1/P2Regenerative Ocular Immunobiologics LLCNCT06852768 Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)oGHVDactive not recruiting15
2026-12 est.P3Sound Pharmaceuticals, Incorporated SOGPNCT06859788 SPI-1005 for the Treatment of Meniere's Disease (Open Label)Meniere's Disease; Ménière's Diseaseactive not recruiting200
2026-12 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06859931 Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)Systemic Lupus Erythematosusnot yet recruiting120
2026-12 est.P1/P2Design Therapeutics, Inc. DSGNNCT06874010 A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's AtaxiaFriedreich Ataxiarecruiting20
2026-12 est.P2Jina Pharmaceuticals Inc.NCT06890832 A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate CancerMetastatic Castration-resistant Prostate Cancer, MCRPCnot yet recruiting75
2026-12 est.P2jCyte, IncNCT06912633 Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)Retinitis Pigmentosaactive not recruiting31
2026-12 est.P2Shandong Suncadia Medicine Co., Ltd.NCT06915142 A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant TumourAdvanced Malignant Tumourrecruiting300
2026-12 est.P2Qilu Pharmaceutical Co., Ltd.NCT06942767 Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or GastroesophagGastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinomanot yet recruiting100
2026-12 est.P1/P2AkesoNCT06943820 AK129 Combination Therapy for Advanced Solid TumorsNon-small Cell Lung Cancer Stage IIIB/IV; Head and Neck Squamous Cell Carcinoma (HNSCC); Colorectal recruiting230
2026-12 est.P3Veradermics, Inc. MANENCT06972264 Safety and Efficacy of VDPHL01 in Males With AGAAndrogenetic Alopecia; AGA; Male Pattern Baldnessactive not recruiting480
2026-12 est.P3Fujian Shengdi Pharmaceutical Co., Ltd.NCT06974851 A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and ObesityBstructive Sleep Apnea (OSA) and Obesityrecruiting140
2026-12 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT06974929 A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast CancerBreast Cancerrecruiting80
2026-12 est.P2Ryvu Therapeutics SANCT06987058 RVU120 Rollover StudyAdvanced Solid Tumors; Acute Myeloid Leukaemia (AML); High-risk Myelodysplastic Syndromeenrolling by invitation14
2026-12 est.P3Minghui Pharmaceutical (Hangzhou) LtdNCT06989918 MHB018A Treatment in Patients With Active Thyroid Eye DiseaseThyroid Associated Ophthalmopathiesactive not recruiting108
2026-12 est.P3Fujian Shengdi Pharmaceutical Co., Ltd.NCT06994650 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With OSubjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapyactive not recruiting144
2026-12 est.P1/P2Krystal Biotech, Inc. KRYSNCT06999733 A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic KeratitisNeurotrophic Keratitisrecruiting60
2026-12 est.P3Praxis Precision Medicines PRAXNCT07010471 A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineDevelopmental and Epileptic Encephalopathy 1active not recruiting160
2026-12 est.P3Krystal Biotech, Inc. KRYSNCT07016750 A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis BullosaDystrophic Epidermolysis Bullosa; DEB - Dystrophic Epidermolysis Bullosa; Recessive Dystrophic Epiderecruiting16
2026-12 est.P3Praxis Precision Medicines PRAXNCT07019922 A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyEpileptic Encephalopathy; SCN2A Encephalopathyrecruiting40
2026-12 est.P2Imbria Pharmaceuticals, Inc.NCT07023614 A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic CardiomyopathyNon-obstructive Hypertrophic Cardiomyopathyrecruiting165
2026-12 est.P2iRegene Therapeutics Co., Ltd.NCT07028632 The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's DiseaseParkinson Disease (PD)not yet recruiting30
2026-12 est.P3Atea Pharmaceuticals, Inc. AVIRNCT07037277 C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVHEPATITIS C VIRUS CHRONIC INFECTION; Hepatitis C, Chronic; Hepatitis C Virus Infection; Hepatitis Cactive not recruiting880
2026-12 est.P3Kedrion S.p.A.NCT07059000 A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)Chronic Primary Immune Thrombocytopenia (ITP)recruiting40
2026-12 est.P2Galderma R&DNCT07074977 Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)Chronic Pruritus of Unknown Originactive not recruiting50
2026-12 est.P3Qilu Pharmaceutical Co., Ltd.NCT07089186 Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsHospital-acquired Bacterial Pneumonia (HABP); Ventilator-associated Bacterial Pneumonia (VABP); Comprecruiting80
2026-12 est.P3CelltrionNCT07093476 Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and MetforminT2DM; Diabete Type 2; DMrecruiting171
2026-12 est.P3Vir Biotechnology, Inc. VIRNCT07128550 A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideViral Hepatitisactive not recruiting150
2026-12 est.P1/P2Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.NCT07136285 Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLCSCLC, Extensive Stagerecruiting27
2026-12 est.P1/P2EicOsis Human Health Inc.NCT07142044 Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)Parkinson's Disease (PD)recruiting18
2026-12 est.P1/P2One-carbon Therapeutics ABNCT07151040 Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid TumorsSolid Tumor; Colorectal Cancer (CRC); Squamous Cell Carcinoma of Head and Neck; Non-Small Cell Lung recruiting43
2026-12 est.P2Eli Lilly and Company LLYNCT07169851 A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerNausea; Vomiting; Drug-Related Side Effects and Adverse Reactions; Neoplasmsrecruiting204
2026-12 est.P3Otsuka Pharmaceutical Co., Ltd.NCT07173478 A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic DermatitisAtopic Dermatitis (AD)not yet recruiting156
2026-12 est.P2Avalyn Pharma Inc. AVLNNCT07194382 AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPFIdiopathic Pulmonary Fibrosis (IPF)recruiting160
2026-12 est.P1/P2Qilu Pharmaceutical Co., Ltd.NCT07198633 A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate CancerAdvanced Prostate Cancerrecruiting212
2026-12 est.P2Elion Therapeutics, Inc.NCT07215273 Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal TherapyInvasive Mould Infectionrecruiting60
2026-12 est.P3Vanda Pharmaceuticals VNDANCT07221578 Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety DisorderSocial Anxiety Disorder (SAD)active not recruiting500
2026-12 est.P2Shandong Suncadia Medicine Co., Ltd.NCT07229950 A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel DiseaseAdult Patients With Moderately to Severely Active Ulcerative Colitisrecruiting48
2026-12 est.P1/P2Ingenia Therapeutics INCNCT07231679 A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney DiseaseHealthy Volunteers; Chronic Kidney Diseaserecruiting94
2026-12 est.P3Grand Shuyang Life Sciences (Chengdu) Co., Ltd.NCT07233213 An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)recruiting36
2026-12 est.P2Shenyang Sunshine Pharmaceutical Co., LTD.NCT07233850 A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal CancersGastric/Gastroesophageal Junction Adenocarcinoma; Metastatic Colorectal Cancer (CRC); Pancreatic Ducnot yet recruiting300
2026-12 est.P2Dong-A ST Co., Ltd.NCT07239440 Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Diabete Mellitusnot yet recruiting288
2026-12 est.P2Ventus Therapeutics U.S., Inc.NCT07260877 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Cutaneous Lupus Erythematosus (CLE); Systemic Lupus Erythematosus; SLE; SLE (Systemic Lupus); CLEactive not recruiting24
2026-12 est.P2Novaliq GmbHNCT07285070 Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisNon-infectious Anterior Uveitisactive not recruiting20
2026-12 est.P2/P3Intra-IMMUSG Pte LtdNCT07290088 Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor PatientsAdvanced Solid Cancersrecruiting52
2026-12 est.P2Fujian Shengdi Pharmaceutical Co., Ltd.NCT07297797 Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate HypertensionMild to Moderate Hypertensionactive not recruiting238
2026-12 est.P2Enveda TherapeuticsNCT07298395 Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisAtopic Dermatitis (AD)recruiting105
2026-12 est.P2Enveda TherapeuticsNCT07301255 ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in AdultsAsthmarecruiting50
2026-12 est.P2Henan Genuine Biotech Co., Ltd.NCT07308782 A Phase Ⅱa Clinical Study of CL-197 CapsulesHIV-1 Infectionrecruiting24
2026-12 est.P2VapeAwayNCT07322432 The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette ReductionAddiction Nicotinerecruiting70
2026-12 est.P2Pulmovant, Inc.NCT07333183 A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDPulmonary Hypertension; Interstitial Lung Disease (ILD); Lung Diseases; Vascular Diseases; Cardiovasrecruiting20
2026-12 est.P2Next Life SciencesNCT07361120 Plan A Occlusion and Reversal System Feasibility StudyFertility; Fertility, Male; Healthy Male Adultsrecruiting40
2026-12 est.P2Traws Pharma, Inc. TRAWNCT07371650 This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaInfluenzaactive not recruiting105
2026-12 est.P2Toll Biotech Co. Ltd. (Beijing)NCT07408024 Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid ArthritisRheumatoid Arthritis (RA)recruiting24
2026-12 est.P2Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.NCT07413094 Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDSSepsisrecruiting309
2026-12 est.P1/P2PT. Prodia Stem Cell IndonesiaNCT07439848 Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for SepsisAcute Respiratory Distress Syndromerecruiting15
2026-12 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT07472725 A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled Diabetes Mellitus, Type 2active not recruiting102
2026-12 est.P2Enanta Pharmaceuticals, Inc ENTANCT07482657 A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial VirRSV Infection; RSV; Respiratory Syncytial Virus (RSV)recruiting150
2026-12 est.P3Qilu Pharmaceutical Co., Ltd.NCT07487103 Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 DiabetesType 2 Diabetesnot yet recruiting478
2026-12 est.P3Qilu Pharmaceutical Co., Ltd.NCT07489586 A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular DegenerationNeovascular Age-Related Macular Degeneration (nAMD)not yet recruiting356
2026-12 est.P2Qilu Pharmaceutical Co., Ltd.NCT07489612 QLS1410 in Participants With Uncontrolled HypertensionHypertension (HTN)enrolling by invitation260
2026-12 est.P3Vergent Bioscience, Inc.NCT07499674 Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the LungLung Cancer; Lung Metastasesrecruiting132
2026-12 est.P2Kardigan, Inc. KARDNCT07511361 Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe HypertensionHypertension; Acute Severe Hypertension; Hypertensive Emergency; Hypertensive Urgencyrecruiting140
2026-12 est.P2Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.NCT07513454 A Phase 2 Study of HW211026Actinic Keratosisnot yet recruiting80
2026-12 est.P2/P3Oculis OCSNCT07548632 A Clinical Study Evaluating Licaminlimab for Dry Eye DiseaseDry Eye Disease (DED)active not recruiting160
2026-12 est.P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT07576608 A Phase II Study of 9MW3811 in Patients With Pathological ScarScarrecruiting30
2026-12 est.P2Chengdu Suncadia Medicine Co., Ltd.NCT07613866 A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous UrticariaChronic Spontaneous Urticarianot yet recruiting190
2026-12 est.P3Chengdu Kangnuoxing Biopharma,Inc.NCT07678931 Study on the Treatment of Adolescent Patients With Seasonal Allergic RhinitisSeasonal Allergic Rhinitis (SAR)recruiting136
2026-12 est.P3Guangdong Hengrui Pharmaceutical Co., LtdNCT07688772 A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisSeasonal Allergic Rhinitisactive not recruiting220
2026-12 est.P1/P2Heron Neutron Medical Corp.NCT07691775 A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid TumorsSolid Tumorrecruiting30
2026-12 est.P2Connect Biopharm LLC CNTBNCT07705737 Rademikibart IV for Acute Asthma and COPD ExacerbationAsthma Acute; COPD Exacerbation Acuterecruiting40
2026-12 est.P2Fujian Shengdi Pharmaceutical Co., Ltd.NCT07709897 A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and VomitingPrevention of Postoperative Nausea and Vomitingrecruiting260
2026-12 est.P3Harrow Inc HROWNCT07832552 A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic SurgPostoperative Ocular Inflammation; Postoperative Ocular Painenrolling by invitation250
2026-12 est.P2Thiogenesis Therapeutics, Inc. TTIPFNCT07837726 Pilot Study of TTI-0102 in CystinosisNephropathic Cystinosis; Cystinosisnot yet recruiting6
2026-12 est.P1/P2DaniscoNCT07893288 A Study of Single and Combination Lipase Dietary Supplements to Increase Fatty Acid Absorption in Generally Health AdultsDigestive Symptoms; Gastrointestinal Symptoms; Healthy; Impaired Pancreatic Functionnot yet recruiting50
2026-12 est.P2/P3Dexa Medica GroupNCT07937462 The Efficacy and Safety of DLBS1442 in Patients With Primary DysmenorrheaPrimary Dysmenorrhearecruiting210
2026-12-01 est.P3Janssen Research & Development, LLCNCT03767244 A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyProstatic Neoplasmsactive not recruiting2517
2026-12-01 est.P2Intra-IMMUSG Pte LtdNCT04452955 A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid TumorsSolid Tumoractive not recruiting51
2026-12-01 est.P2EpicentRx, Inc.NCT04673942 A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsSolid Tumor, Adult; Cancer; Neoplasms; Sarcoma; Sarcoma,Soft Tissue; Chondrosarcomaactive not recruiting140
2026-12-01 est.P3OctapharmaNCT04918173 Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or DeliveryCongenital Antithrombin Deficiencyrecruiting38
2026-12-01 est.P2K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncNCT05128825 A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerHigh-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancerrecruiting310
2026-12-01 est.P2/P3Shanghai Pharmaceuticals Holding Co., LtdNCT05860465 Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast CancerLocally Advanced or Metastatic Breast Cancerrecruiting254
2026-12-01 est.P3Tasly Pharmaceutical Group Co., LtdNCT06000956 A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and PlaceboAnkylosing Spondylitisrecruiting408
2026-12-01 est.P2Cartesian Therapeutics RNACNCT06038474 Descartes-08 for Patients With Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE)active not recruiting6
2026-12-01 est.P1/P2FindCure Biosciences (ZhongShan) Co., Ltd.NCT06499350 A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid TumorsAdvanced Malignant Solid Tumorsrecruiting33
2026-12-01 est.P1/P2AP Biosciences Inc.NCT06669975 A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid TumorsAdvanced Solid Tumorrecruiting85
2026-12-01 est.P2Beijing Biostar Pharmaceuticals Co., Ltd.NCT06683703 Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNon-small Cell Lung Cancer Patients with Brain Metastasesnot yet recruiting118
2026-12-01 est.P3Biogen BIIBNCT06685757 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)Antibody-mediated Rejectionactive not recruiting132
2026-12-01 est.P3Shanghai Vitalgen BioPharma Co., Ltd.NCT06699108 Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline DystrophyBietti Crystalline Dystrophy; Inherited Retinal Diseasesactive not recruiting45
2026-12-01 est.P3Sanofi Pasteur, a Sanofi Company SNYNCT06838000 Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, aPneumococcal Infectionsactive not recruiting1268
2026-12-01 est.P1/P2CellARTs Inc.NCT06841861 Spermatogonial Differentiation Via Testicular OrganoidInfertility, Male; Gene Abnormality; Sterility, Malerecruiting100
2026-12-01 est.P2Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.NCT06858618 FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid NeoplasmsSafety; Antitumor Activity; PK Profileactive not recruiting47
2026-12-01 est.P1/P2Sanofi SNYNCT06907511 Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain Pandemic Influenza Immunization; Healthy Volunteersactive not recruiting720
2026-12-01 est.P2/P3HealthBio, Inc.NCT06974084 A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of MaraLong COVIDnot yet recruiting252
2026-12-01 est.P3Virchow GroupNCT07017036 Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID PatientsPrimary Immunodeficiency Diseases (PID)not yet recruiting44
2026-12-01 est.P3Fujian Akeylink Biotechnology Co., Ltd.NCT07090759 To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to AntiChronic Hepatitis brecruiting526
2026-12-01 est.P3Guangdong Raynovent Biotech Co., LtdNCT07139535 A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneT2DMnot yet recruiting350
2026-12-01 est.P3Guangdong Raynovent Biotech Co., LtdNCT07139548 A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 DiabetesT2DMnot yet recruiting600
2026-12-01 est.P1/P2ASTEROGENE Biomedical Co. Ltd.NCT07168603 EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc DiseaseIntervertebral Disc Degenerationrecruiting12
2026-12-01 est.P3JYAMS PET Research & Development LimitedNCT07422857 Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive FunctionSubjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementiarecruiting316
2026-12-01 est.P3Vanda Pharmaceuticals VNDANCT07446439 A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseNausea and Vomiting; Obesityrecruiting280
2026-12-02 est.P3Pfizer PFENCT07029711 A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia AreataSevere Alopecia Areataactive not recruiting208
2026-12-03 est.P2Regeneron Pharmaceuticals REGNNCT06421636 A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult ParticipantNon-Transfusion Dependent Beta-Thalassemia (NTDT)active not recruiting19
2026-12-03 est.P2Eisai Inc.NCT06602258 A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseAlzheimer's Diseaseactive not recruiting105
2026-12-03 est.P2Novartis Pharmaceuticals NVSNCT06991556 An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Metastatic Hormone-sensitive Prostate Canceractive not recruiting168
2026-12-04 est.P3Pfizer PFENCT07500506 A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease VaccineLyme Diseaserecruiting1712
2026-12-05 est.P1/P2Suzhou Forlong Biotechnology Co., LtdNCT07131202 A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid TumorsAdvanced Solid Tumorsrecruiting130
2026-12-05 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT07616700 A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA NephropathyIgA Nephropathy (IgAN)recruiting73
2026-12-07 est.P3Alexion Pharmaceuticals, Inc.NCT06724809 Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSDNMOSD; Neuromyelitis Optica Spectrum Disordersactive not recruiting21
2026-12-08 est.P3Janssen Research & Development, LLCNCT05757869 A Study of Milvexian Versus Apixaban in Participants With Atrial FibrillationAtrial Fibrillationactive not recruiting20284
2026-12-08 est.P2Pfizer PFENCT07228390 A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, HidradenitiHidradenitis Suppurativaactive not recruiting128
2026-12-09 est.P3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT06126224 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)Psychosis Associated With Alzheimer's Diseaserecruiting500
2026-12-09 est.P1/P2SK Bioscience Co., Ltd.NCT07280858 A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy AdultHealthy Participants; Sarbecovirusactive not recruiting368
2026-12-10 est.P2Shanghai Pharmaceuticals Holding Co., LtdNCT05686642 Efficacy and Safety of LT3001 on Treating the Acute Ischemic StrokeAcute Ischemic Strokerecruiting300
2026-12-10 est.P3Boehringer IngelheimNCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With StandarLung Cancer, Non-squamous, Non-small Cellactive not recruiting428
2026-12-10 est.P2AstraZeneca AZNNCT07222917 A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic KiChronic Kidney Disease and Hypertensionactive not recruiting222
2026-12-11 est.P2GlaxoSmithKlineNCT03441113 Extended Access of Momelotinib in Adults With MyelofibrosisPrimary Myelofibrosisactive not recruiting237
2026-12-11 est.P2Seagen, a wholly owned subsidiary of PfizerNCT04879329 A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Urothelial Carcinomarecruiting372
2026-12-12 est.P2Ausper Biopharma Co., Ltd.NCT07137910 A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)Chronic Hepatitis Brecruiting200
2026-12-12 est.P2Beijing QL Biopharmaceutical Co.,LtdNCT07230132 Efficacy and Safety of ZT006 in Overweight and Obese ParticipantsOverweight , Obesityactive not recruiting184
2026-12-12 est.P3CSPC Megalith Biopharmaceutical Co.,Ltd.NCT07376382 A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLCNSCLCnot yet recruiting680
2026-12-12 est.P2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07729475 A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular EventsElevated Lipoprotein(a)not yet recruiting120
2026-12-13 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT04957550 To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic ArthritisPsoriatic Arthritisactive not recruiting418
2026-12-14 est.P2Bristol-Myers Squibb BMYNCT06122779 Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)Heart Failureactive not recruiting227
2026-12-14 est.P2GlaxoSmithKlineNCT06317311 A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerCarcinomaactive not recruiting41
2026-12-14 est.P3Amgen AMGNNCT06430866 Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)active not recruiting163
2026-12-14 est.P3GlaxoSmithKlineNCT06806137 A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First DoseChickenpoxrecruiting600
2026-12-14 est.P2Novo Nordisk A/S NVONCT07184632 A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityOverweight; Obesityactive not recruiting224
2026-12-14 est.P2Beijing Tide Pharmaceutical Co., LtdNCT07543796 Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)Postoperative Analgesia After Unilateral Hip Arthroplastyrecruiting200
2026-12-15 est.P3Gedeon Richter Plc.NCT03817502 Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaSchizophreniarecruiting330
2026-12-15 est.P1/P2PMV Pharmaceuticals, Inc PMVPNCT04585750 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Advanced Solid Tumor; Advanced Malignant Neoplasm; Metastatic Cancer; Metastatic Solid Tumor; Lung Crecruiting300
2026-12-15 est.P2/P3Janssen Research & Development, LLCNCT05327114 Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyradiculoneuropathy, Chronic Inflammatory Demyelinatingrecruiting201
2026-12-15 est.P1/P2GV20 TherapeuticsNCT05669430 A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesSolid Tumor, Adult; Refractory Cancer; Endometrial Carcinoma (EC); Squamous Head and Neck Carcinoma;recruiting365
2026-12-15 est.P3Exelixis EXELNCT05678673 Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaNon-Clear Cell Renal Cell Carcinomaactive not recruiting317
2026-12-15 est.P1/P2PLL TX AUSTRALIA PTY LTDNCT06513546 A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS PatientsAmyotrophic Lateral Sclerosis; ALSnot yet recruiting153
2026-12-15 est.P3Alexion Pharmaceuticals, Inc.NCT06607627 PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia GravisGeneralized Myasthenia Gravis; gMGrecruiting12
2026-12-15 est.P2EXACT Therapeutics ASNCT06850623 Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic CancerLocally Advanced Pancreatic Adenocarcinomarecruiting25
2026-12-15 est.P2Cerus Corporation CERSNCT07015437 A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1Healthy Subjectsrecruiting120
2026-12-15 est.P3IpsenNCT07427797 A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsModerate to Severe Glabellar Linesactive not recruiting309
2026-12-15 est.P3IpsenNCT07435428 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsModerate to Severe Glabellar Linesactive not recruiting1300
2026-12-16 est.P3Hoffmann-La RocheNCT05503264 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid ReNMDAR Autoimmune Encephalitis; LGI1 Autoimmune Encephalitisactive not recruiting122
2026-12-16 est.P3Shanghai JMT-Bio Inc.NCT06747338 A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast CancerEarly or Locally Advanced HER2-positive Breast Canceractive not recruiting520
2026-12-17 est.P2Bristol-Myers Squibb BMYNCT06268886 Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseAlzheimer Disease, Early Onsetactive not recruiting310
2026-12-17 est.P3IpsenNCT06730061 A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)Primary Biliary Cholangitisactive not recruiting18
2026-12-17 est.P2Sanofi SNYNCT06958536 A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's DiseaseCrohn's Diseaserecruiting99
2026-12-17 est.P2Sanofi SNYNCT06975722 A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative ColitisUlcerative Colitisactive not recruiting105
2026-12-17 est.P3Takeda TAKNCT07363720 A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyNarcolepsy Type 1 (NT1); Narcolepsy With Cataplexyactive not recruiting98
2026-12-18 est.P2/P3Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairNCT06062810 Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide PolymorphismsBreast Canceractive not recruiting600
2026-12-18 est.P2/P3Han Xu, M.D., Ph.D., FAPCR, Medical Director, IRB ChairNCT07145333 Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide PolymorphismsSCLCactive not recruiting600
2026-12-18 est.P3Ausper Biopharma Co., Ltd.NCT07246889 Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)Chronic Hepatitis Bactive not recruiting577
2026-12-20 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT07158268 A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque PsoriasisPlaque Psoriasisnot yet recruiting220
2026-12-20 est.P3TJ Biopharma Co., Ltd.NCT07208058 A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic DisRelapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosisrecruiting30
2026-12-21 est.P3UCB Biopharma SRLNCT06921850 A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativaactive not recruiting43
2026-12-22 est.P1/P2Merck Sharp & Dohme LLC MRKNCT05468697 A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LIRenal Cell Carcinomaactive not recruiting60
2026-12-22 est.P2Janssen Pharmaceutica N.V., BelgiumNCT06544616 A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseAlzheimer Diseaseactive not recruiting55
2026-12-22 est.P2Boehringer IngelheimNCT06769048 A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyGeographic Atrophyactive not recruiting150
2026-12-22 est.P3Adverum Biotechnologies, Inc.NCT06856577 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular DegenerationNeovascular Age-Related Macular Degeneration (nAMD); Wet AMDactive not recruiting311
2026-12-22 est.P3Taisho Pharmaceutical Co., Ltd.NCT07285291 A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate BindersHyperphosphatemia Patients on Hemodialysisrecruiting100
2026-12-22 est.P2Healthgen Biotechnology Corp.NCT07893600 Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.Gastric Mucosal Lesionnot yet recruiting40
2026-12-23 est.P3R-BioNCT04427930 Follow-up Study for Participants of Jointstem Phase 3 Clinical TrialKnee Osteoarthritisactive not recruiting129
2026-12-23 est.P3AstraZeneca AZNNCT05692180 A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of BenralizumAsthmaactive not recruiting94
2026-12-23 est.P2Novartis Pharmaceuticals NVSNCT05849298 A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPCProstatic Neoplasmactive not recruiting49
2026-12-23 est.P1/P2Cho Pharma Inc.NCT05950165 A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's LymphomaNon-Hodgkin Lymphomaactive not recruiting37
2026-12-23 est.P2Fusion Pharmaceuticals Inc. HTOONCT06402331 FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Metastatic Castration-resistant Prostate Canceractive not recruiting110
2026-12-23 est.P2Sanofi SNYNCT06500702 A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental GlomeruFocal Segmental Glomerulosclerosis; Glomerulonephritis Minimal Lesionrecruiting84
2026-12-23 est.P2Changchun GeneScience Pharmaceutical Co., Ltd.NCT07260500 A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and PharmacokineticsShort Stature Children Born Small for Gestational Age (SGA)recruiting72
2026-12-23 est.P3OncoZenge ABNCT07672236 A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.Head & Neck Cancer; Oral Mucositisrecruiting150
2026-12-24 est.P3Shanghai Kechow Pharma, Inc.NCT06008119 Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal CancerColorectal Cancer Metastaticrecruiting165
2026-12-24 est.P2Nanjing Leads Biolabs Co.,LtdNCT06783647 A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]Advanced Solid Tumourrecruiting250
2026-12-25 est.P3Jiangsu Healthy Life Innovation Medical Technology Co., LtdNCT05653453 Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic CancerLocally Advanced Pancreatic Cancerrecruiting512
2026-12-25 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06525350 A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel(Albumin Bound)Verse Docetaxel for the Treatment of MET-overexpressed Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpressionot yet recruiting256
2026-12-25 est.P3GlaxoSmithKlineNCT06740630 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of AgeChickenpoxrecruiting1840
2026-12-25 est.P2Pfizer PFENCT07219615 A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.Chronic Spontaneous Urticariarecruiting200
2026-12-26 est.P3CanariaBio Inc.NCT04498117 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking SurgeryCarcinoma, Ovarian Epithelial; Ovarian Neoplasms; Ovarian Cancer; Ovarian Serous Adenocarcinoma; Falactive not recruiting615
2026-12-26 est.P3Incyte Corporation INCYNCT06212999 A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativa (HS)active not recruiting617
2026-12-27 est.P1/P2Stemline Therapeutics, Inc.NCT05563220 Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast CancerBreast Cancer; Metastatic Breast Canceractive not recruiting435
2026-12-27 est.P2AkesoNCT07436221 A Study to Evaluate the Efficacy and Safety of AK139 in Participants With AsthmaAsthmanot yet recruiting160
2026-12-27 est.P2Dompé Farmaceutici S.p.ANCT07503886 An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseaseDry Eye Disease (DED)recruiting417
2026-12-27 est.P2Amplexd Therapeutics, Inc.NCT07572396 Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic AbnormalitiesHigh-risk HPV (Any Strain); LSIL, Low Grade Squamous Intraepithelial Lesion; ASC-US; HPV Infection; recruiting45
2026-12-28 est.P1/P2Hoffmann-La RocheNCT04077723 A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination WitLymphoma, Non-Hodgkinactive not recruiting498
2026-12-28 est.P2GlaxoSmithKlineNCT04641247 A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyOvarian Neoplasms; Breast Neoplasmsrecruiting37
2026-12-28 est.P1/P2Beijing InnoCare Pharma Tech Co., Ltd.NCT05210868 A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)Hematomaactive not recruiting184
2026-12-28 est.P2Frantz Viral Therapeutics, LLCNCT05555862 Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSILAnal High Grade Squamous Intraepithelial Lesion; Anal Precancerous Condition; AIN 2/3; HPV Infectionactive not recruiting17
2026-12-28 est.P1/P2Chengdu Origen Biotechnology Co., Ltd.NCT05672121 Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Age-Related Macular Degenerationrecruiting42
2026-12-28 est.P1/P2Nanjing Leads Biolabs Co.,LtdNCT06157827 A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine CarcinomaAdvanced Neuroendocrine Carcinomarecruiting178
2026-12-28 est.P3Jiangsu Topcel-KH Pharmaceutical Co., Ltd.NCT06925594 Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's DiseaseCrohn's Diseaserecruiting228
2026-12-28 est.P3GlaxoSmithKlineNCT07645248 A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)Asthmarecruiting110
2026-12-29 est.P2Suzhou Sanegene Bio Inc.NCT06786338 A Study of SGB-9768 in Patients With Complement-mediated Kidney DiseasesIgA Nephropathy (IgAN); C3 Glomerulopathy; IC-MPGNactive not recruiting45
2026-12-29 est.P2Regeneron Pharmaceuticals REGNNCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have HypercholesterolemiaHypercholesterolemiaactive not recruiting438
2026-12-29 est.P2Arctic TherapeuticsNCT07716865 Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)Hereditary Cystatin C Amyloid Angiopathy (HCCAA); Hemorrhage Brain; Hemorrhage Cerebralactive not recruiting15
2026-12-30 est.P2Teclison Ltd.NCT03259867 Combination of TATE and PD-1 Inhibitor in Liver CancerHepatocellular Carcinoma; Gastric Cancerrecruiting54
2026-12-30 est.P1/P2Supernus Pharmaceuticals, Inc. SUPNNCT03474770 BIS-001-ER for the Treatment of Adult Focal Impaired Awareness SeizuresFocal Impaired Awareness Seizuresactive not recruiting16
2026-12-30 est.P3Xynomic Pharmaceuticals, Inc.NCT03592472 A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Renal Cell Carcinomarecruiting413
2026-12-30 est.P23D Medicines (Sichuan) Co., Ltd.NCT03667170 KN035 for dMMR/MSI-H Advanced Solid TumorsSolid Tumoractive not recruiting188
2026-12-30 est.P1/P2Bionic Sight LLCNCT04278131 BS01 in Patients With Retinitis PigmentosaRetinitis Pigmentosarecruiting20
2026-12-30 est.P1/P2Sellas Life Sciences Group SLSNCT04588922 Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLHematologic Malignanciesrecruiting160
2026-12-30 est.P3Janssen Research & Development, LLCNCT04658862 A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the BladderUrinary Bladder Neoplasmsactive not recruiting518
2026-12-30 est.P2Neonc Technologies, Inc. NTHINCT05023018 NEO100 and High-Grade MeningiomaResidual, Progressive or Recurrent Grade II or III Meningiomarecruiting30
2026-12-30 est.P2AkesoNCT05227664 A Study of AK117/AK112 in Metastatic Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer; Locally Advanced Triple-negative Breast Canceractive not recruiting120
2026-12-30 est.P2NATCO Pharma Ltd.NCT05283226 Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Carcinoma; Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomarecruiting21
2026-12-30 est.P2CanariaBio Inc.NCT05335993 A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.Recurrent Ovarian Cancer; Recurrent Epithelial Cancer of Ovary; Recurrent Epithelial Ovarian Cancer;active not recruiting10
2026-12-30 est.P2Ganzhou Hemay Pharmaceutical Co., LtdNCT05486104 Phase II Study of Hemay005 in Patients With Active Ulcerative ColitisModerate to Severe Ulcerative Colitisactive not recruiting92
2026-12-30 est.P2Chengdu Zenitar Biomedical Technology Co., LtdNCT05563844 Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)Diffuse Large B Cell Lymphoma,DLBCLactive not recruiting74
2026-12-30 est.P2Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. SKBBYNCT05631262 SKB264 Monotherapy in Selected Subjects With Advanced Solid TumorsSelected Subjects With Advanced Solid Tumorsactive not recruiting321
2026-12-30 est.P2/P3Quoin Pharmaceuticals QNRXNCT05789056 Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNetherton Syndromerecruiting20
2026-12-30 est.P3Pfizer PFENCT05909397 Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast CancerBreast Canceractive not recruiting59
2026-12-30 est.P1/P2Suzhou Abogen Biosciences Co., Ltd.NCT06088004 Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid TumorsSolid Tumor, Adultrecruiting218
2026-12-30 est.P3Beijing Konruns Pharmaceutical Co., Ltd.NCT06194734 A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerEsophageal Squamous Cell Carcinomarecruiting490
2026-12-30 est.P3AskGene Pharma, Inc.NCT06206733 ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ AdenocarcinomaGastroesophageal Junction Adenocarcinoma; Gastric Adenocarcinomaactive not recruiting780
2026-12-30 est.P3Innovent Biologics (Suzhou) Co. Ltd.NCT06238843 A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinomaactive not recruiting464
2026-12-30 est.P2Novartis Pharmaceuticals NVSNCT06388941 Iptacopan in Patients With ANCA Associated VasculitisAnti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitisactive not recruiting84
2026-12-30 est.P2/P3Shanghai Jiaolian Drug Research and Development Co., LtdNCT06447597 A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.Generalized Myasthenia Gravisrecruiting104
2026-12-30 est.P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06465563 SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract CancerBiliary Tract Canceractive not recruiting93
2026-12-30 est.P1/P2L & L Bio Co., Ltd., Ningbo, ChinaNCT06468358 A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid TumorsSolid Tumorrecruiting194
2026-12-30 est.P2Meribank Biotech Co., Ltd.NCT06491043 Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem CellsChronic Obstructive Pulmonary Diseaserecruiting90
2026-12-30 est.P2Allotera TherapeuticsNCT06514794 A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)T-cell Acute Lymphoblastic Leukemia; Lymphoblastic Lymphomarecruiting125
2026-12-30 est.P2S1 Biopharma, Inc.NCT06516055 Study of S1B-408 in Women With Orgasmic DysfunctionOrgasmic Disordernot yet recruiting30
2026-12-30 est.P2Amorphical Ltd.NCT06547151 Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in AdultsHypoparathyroidismactive not recruiting62
2026-12-30 est.P3Janssen Research & Development, LLCNCT06559306 Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsDepressive Disorder, Majorrecruiting752
2026-12-30 est.P3Jiangsu vcare pharmaceutical technology co., LTDNCT06577519 Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)recruiting1000
2026-12-30 est.P1/P2AkesoNCT06646055 AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic CancerMetastatic Pancreatic Ductal Adenocarcinomaactive not recruiting110
2026-12-30 est.P3Jiangsu vcare pharmaceutical technology co., LTDNCT06658353 Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid TumorsLocally Advanced Solid Tumorrecruiting54
2026-12-30 est.P3Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT06751485 JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian CancerOvarian Cancer; Primary Peritoneal; Fallopian Tube Cancersnot yet recruiting430
2026-12-30 est.P2Swedish Orphan BiovitrumNCT06782373 A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)VEXAS; VEXAS Syndromerecruiting156
2026-12-30 est.P1/P2Astellas Pharma Global Development, Inc.NCT06792435 XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Pancreatic Adenocarcinoma Metastatic; Lung Cancer (NSCLC); Ovarian Cancer; Colorectal Cancer Metastaactive not recruiting240
2026-12-30 est.P3Cartesian Therapeutics RNACNCT06799247 Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisMyasthaenia Gravisactive not recruiting128
2026-12-30 est.P2ThromBio Pty. Ltd.NCT06813651 Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem OcclusionIschemic Stroke; Tandem Occlusionrecruiting78
2026-12-30 est.P1/P24TEEN4 Pharmaceuticals GmbHNCT06832722 A Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care.Shock, Cardiogenicrecruiting90
2026-12-30 est.P2/P3Wuhan Createrna Science and Technology Co., LtdNCT06933914 Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria (PNH)recruiting120
2026-12-30 est.P2/P3Quoin Pharmaceuticals QNRXNCT06953466 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNetherton Syndromerecruiting8
2026-12-30 est.P3Sinovac Biotech Co., Ltd SVANCT07055295 Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis RegimenRabiesnot yet recruiting390
2026-12-30 est.P2Shanghai Henlius BiotechNCT07106892 Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal CancerColorectal Cancer (CRC)recruiting60
2026-12-30 est.P2Lubris Bio Pty LtdNCT07118241 A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPAREDSjögren's Syndromerecruiting80
2026-12-30 est.P2XyloCor Therapeutics, Inc.NCT07118449 Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABGCoronary Artery Disease (CAD)not yet recruiting116
2026-12-30 est.P2/P3Ebima Clifford OkundayeNCT07161843 Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)Acute Renal Failure (ARF); Acute Tubular Necrosisnot yet recruiting500
2026-12-30 est.P2HC Biopharma Inc.NCT07169552 HC010 in First-line PD-L1 Positive Advanced NSCLC PatientsNSCLCrecruiting50
2026-12-30 est.P3Getz PharmaNCT07174297 Acotiamide vs Itopride in Postprandial Distress SyndromePostprandial Distress Syndromenot yet recruiting152
2026-12-30 est.P2ShionogiNCT07214571 A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe DiseaseRespiratory Syncytial Virus Infectionsrecruiting192
2026-12-30 est.P2/P3Beijing Continent Pharmaceutical Co, Ltd.NCT07388680 Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune PneumoniaRadiation-induced Lung Injury; Immune-related Pneumoniarecruiting298
2026-12-30 est.P2Shanghai Henlius BiotechNCT07459738 A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast CaHormone Receptor Positive HER-2 Negative Breast Cancernot yet recruiting60
2026-12-31 est.P2Skingenix, Inc.NCT01297400 Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal BurnsBurnsrecruiting60
2026-12-31 est.P3Janssen Research & Development, LLCNCT01804686 A Long-term Extension Study of PCI-32765 (Ibrutinib)Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Mantle Cell Lymphoma; Follicular Lymphoma;active not recruiting539
2026-12-31 est.P2Partner Therapeutics, Inc.NCT02912949 A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)Solid Tumours Harboring NRG1 Fusion; NSCLC Harboring NRG1 Fusion; Pancreatic Cancer Harboring NRG1 Factive not recruiting250
2026-12-31 est.P2Sclnow Biotechnology Co., Ltd.NCT03383081 The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With OsteoarthritisOsteoarthritis, Kneerecruiting60
2026-12-31 est.P2JCR Pharmaceuticals Co., Ltd.NCT03708965 An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis IIMucopolysaccharidosis IIactive not recruiting19
2026-12-31 est.P3Eisai Inc.NCT03887455 A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseEarly Alzheimer's Diseaseactive not recruiting1906
2026-12-31 est.P3Iperboreal Pharma SrlNCT03994471 Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.End Stage Renal Diseaserecruiting170
2026-12-31 est.P3Amicus TherapeuticsNCT04020055 A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal DiseaseFabry Diseaseactive not recruiting14
2026-12-31 est.P1/P2OncoC4, Inc.NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCNon Small Cell Lung Cancer; Advanced Solid Tumor; Metastatic Melanoma; Metastatic Head and Neck Carcactive not recruiting733
2026-12-31 est.P3BeOne Medicines ONCNCT04170283 A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of ZanubrutiniB-cell Malignanciesactive not recruiting955
2026-12-31 est.P1/P2BicycleTx LimitedNCT04180371 Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionAdvanced Solid Tumor Historically Known for High EphA2 Expression; Urothelial Cancer; Ovarian Canceractive not recruiting288
2026-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04271644 BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell DiseaseMultiple Myeloma; Neoplasm, Plasma Cell; Multiple Myeloma in Relapserecruiting80
2026-12-31 est.P3TRB ChemedicaNCT04318041 Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic PatientsKnee Osteoarthritisactive not recruiting128
2026-12-31 est.P2Pfizer PFENCT04553133 PF-07104091 as a Single Agent and in Combination TherapySmall Cell Lung Cancer; Ovarian Cancer; Breast Canceractive not recruiting157
2026-12-31 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT04691804 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus PlacebMetastatic Castration-Resistant Prostate Cancer (mCRPC)active not recruiting496
2026-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04776330 a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell DiseaseMultiple Myeloma; Neoplasm, Plasma Cell; Multiple Myeloma in Relapserecruiting80
2026-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04781634 a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALLB-ALLrecruiting40
2026-12-31 est.P2Miltenyi Biomedicine GmbHNCT04792489 DALY II USA/ MB-CART2019.1 for DLBCLRefractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B Cell Lymphoma; High Graderecruiting315
2026-12-31 est.P1/P2Kamau TherapeuticsNCT04819841 Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell DiseaseSickle Cell Diseaserecruiting15
2026-12-31 est.P2Mercator MedSystems, Inc.NCT04862468 Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVTThrombosis, Deep Vein; Iliofemoral; Thrombosisrecruiting80
2026-12-31 est.P2GeoVax, Inc. GOVXNCT04977024 SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerCOVID-19 Infection; Hematopoietic and Lymphoid System Neoplasm; Leukemia; Lymphoma; Plasma Cell Myelactive not recruiting63
2026-12-31 est.P2/P3AMO Pharma LimitedNCT05004129 Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic DystrophyCongenital Myotonic Dystrophyrecruiting76
2026-12-31 est.P3Pfizer PFENCT05059522 Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingAdvanced Malignancies; NSCLC; Ovarian Cancer; Urothelial Cancer; Solid Tumorsactive not recruiting77
2026-12-31 est.P2Lumosa Therapeutics Co., Ltd.NCT05198323 A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVTAcute Ischemic Strokeactive not recruiting66
2026-12-31 est.P1/P2AkesoNCT05229497 A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant TumorsAdvanced Malignant Tumorsactive not recruiting154
2026-12-31 est.P2TaiRx, Inc.NCT05257590 CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular CarcinomaHepatocellular Carcinoma; Advanced Cancerrecruiting95
2026-12-31 est.P1/P2Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. SKBBYNCT05265091 A Study of KL590586 in Patients With Advanced Solid TumorsAdvanced Solid Tumoractive not recruiting414
2026-12-31 est.P1/P2Impact Therapeutics, Inc. IBONCT05269316 Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid TumorsSolid Tumor; Advanced Solid Tumorrecruiting61
2026-12-31 est.P3RemeGen Co., Ltd.NCT05302284 A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial CarcinomaUrothelial Carcinoma; HER2-expressingrecruiting452
2026-12-31 est.P3AstraZeneca AZNNCT05303532 Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabCancerenrolling by invitation214
2026-12-31 est.P1/P2Pell Bio-Med Technology Co., Ltd.NCT05326243 Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell LymphomaDiffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma; Large B-cell Lymphoma; Folactive not recruiting49
2026-12-31 est.P2ExcelsiorNCT05413655 A Study of Oral EX039 in Subjects with Mild Alzheimer's DiseaseAlzheimer Diseaserecruiting120
2026-12-31 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT05424835 A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously TreatedHER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzactive not recruiting381
2026-12-31 est.P3Cloudbreak Therapeutics, LLCNCT05456425 A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With PterygiumPterygiumactive not recruiting660
2026-12-31 est.P2MediciNova MNOVNCT05464784 MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaDiabetes Mellitus, Type 2; Hypertriglyceridemia; Non-Alcoholic Fatty Liver Diseaseactive not recruiting40
2026-12-31 est.P1/P2Zhejiang ACEA Pharmaceutical Co. Ltd.NCT05565807 Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Multiple Myelomarecruiting84
2026-12-31 est.P2Hoffmann-La RocheNCT05645692 A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced MetUrothelial Canceractive not recruiting204
2026-12-31 est.P2/P3Insmed Incorporated INSMNCT05649748 An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertensionactive not recruiting91
2026-12-31 est.P2/P3Olatec Therapeutics, Inc.NCT05658575 Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareAcute Gout Flare; Gout Attack; Gout Flare; Gouty Arthritis; Gout; Arthritis; Joint Painrecruiting300
2026-12-31 est.P3Viatris Innovation GmbH VTRSNCT05672576 A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusLupus Erythematosus, Systemicactive not recruiting451
2026-12-31 est.P3AUG TherapeuticsNCT05754450 An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type IILeukocyte Adhesion Deficiencyrecruiting2
2026-12-31 est.P1/P2Lin BioScience, IncNCT05756322 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute LeukaemiasRelapsed or Resistant Acute Leukaemiasrecruiting90
2026-12-31 est.P1/P2AskGene Pharma, Inc.NCT05867420 A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.Advanced Solid Tumorsrecruiting594
2026-12-31 est.P2Shanghai Pharmaceuticals Holding Co., LtdNCT05872347 Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.Breast Cancer Brain Metastasesrecruiting52
2026-12-31 est.P2Hoffmann-La RocheNCT05910528 Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's DiseaseCrohns Diseaseactive not recruiting21
2026-12-31 est.P1/P2Clearmind Medicine Inc. CMNDNCT05913752 A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) SubjectsAlcohol Use Disorderrecruiting84
2026-12-31 est.P1/P2Shanghai Pharmaceuticals Holding Co., LtdNCT05944224 A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.Advanced Solid Tumorsrecruiting63
2026-12-31 est.P1/P2Asia Cell Therapeutics (Shanghai) Co., Ltd.NCT05948982 Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B CirrhosisDecompensated Liver Cirrhosisnot yet recruiting18
2026-12-31 est.P2Allist Pharmaceuticals, Inc.NCT06008288 A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.KRAS P.G12C; Pancreatic Cancer; Solid Tumorrecruiting88
2026-12-31 est.P1/P2Aveta Biomics, Inc.NCT06011109 Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and BevacizumabGlioma; Glioblastoma Multiformeactive not recruiting30
2026-12-31 est.P3Teva Branded Pharmaceutical Products R&D LLCNCT06052267 A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsAsthmaactive not recruiting2769
2026-12-31 est.P1/P2Chimeric TherapeuticsNCT06055439 A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell TherapyNeuroendocrine Tumors; Colorectal Cancer; Gastric Canceractive not recruiting135
2026-12-31 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT06079112 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial CancerAdvanced Urothelial Carcinomarecruiting100
2026-12-31 est.P3Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. SKBBYNCT06081959 Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast CancerMetastatic Breast Cancerrecruiting376
2026-12-31 est.P1/P2Bio-Thera SolutionsNCT06094179 Evaluate the Safety, Tolerability of BAT6026Dermatitis, Atopicactive not recruiting33
2026-12-31 est.P3Ascentage Pharma Group Inc. AAPGNCT06104566 Global Trial in APG2575 for Patients With CLL/SLLCLL/SLLrecruiting400
2026-12-31 est.P2/P3Guangzhou JOYO Pharma Co., LtdNCT06125327 SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosisrecruiting210
2026-12-31 est.P3Hangzhou Gensciences Biopharmaceutical Co., Ltd.NCT06136507 Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia ASevere Hemophilia Anot yet recruiting76
2026-12-31 est.P1/P2Sarepta Therapeutics, Inc. SRPTNCT06138743 Study of SRP-1003 in Participants With Type 1 Myotonic DystrophyMyotonic Dystrophy 1enrolling by invitation78
2026-12-31 est.P2Rhizen Pharmaceuticals SANCT06189209 Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)Triple Negative Breast Cancer (TNBC)recruiting40
2026-12-31 est.P2Azure Biotech Inc.NCT06197568 Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal WomenVulvo Vaginal Atrophy (VVA)recruiting90
2026-12-31 est.P2Frantz Viral Therapeutics, LLCNCT06206564 Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative ParticipantsAnal High-grade Squamous Intraepithelial Lesion; Anal HSIL; Anal HPV Infection; AINrecruiting48
2026-12-31 est.P1/P2Shanghai Pharmaceuticals Holding Co., LtdNCT06214143 A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid TumorsAdvanced Solid Tumorsrecruiting68
2026-12-31 est.P1/P2Arsenal Biosciences, Inc.NCT06245915 AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)Advanced/Metastatic Clear Cell Renal Cell Carcinoma; Recurrenceactive not recruiting37
2026-12-31 est.P3Serum Institute of India Pvt. Ltd.NCT06281119 Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 YearsHuman Papillomavirus Infectionactive not recruiting450
2026-12-31 est.P3Materia Medica HoldingNCT06284265 Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial CystitisCystitis Chronic; Cystitis Bacterial; Recurrence of Chronic Bacterial Cystitisactive not recruiting415
2026-12-31 est.P1/P2ENCellNCT06328712 Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; PhaCharcot-Marie-Tooth Disease Type 1Arecruiting27
2026-12-31 est.P1/P2Avistone Biotechnology Co., Ltd.NCT06343064 Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKINon-Small-Cell Lung Cancerrecruiting156
2026-12-31 est.P2Abscint NV/SANCT06369831 HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011Metastatic Breast Cancer; Metastatic Solid Cancerrecruiting60
2026-12-31 est.P1/P2Genfleet Therapeutics (Shanghai) Inc.NCT06375733 A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCLLarge B-cell Lymphomarecruiting51
2026-12-31 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT06413745 Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract CanHER2 Expression / Amplification in Patients With Biliary Tract Canceractive not recruiting59
2026-12-31 est.P2Shanghai Pharmaceuticals Holding Co., LtdNCT06434597 A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.Biliary Tract or Colorectal Cancer With Her2-positive/Mutatedrecruiting60
2026-12-31 est.P2Shanghai Jiaolian Drug Research and Development Co., LtdNCT06434610 A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.Platinum-resistant Recurrent Ovarian Cancerrecruiting90
2026-12-31 est.P2/P3Shanghai Jiaolian Drug Research and Development Co., LtdNCT06454357 A Clinical Study of B007 in the Treatment of Pemphigus.Pemphigusrecruiting132
2026-12-31 est.P2/P3Shanghai Jiaolian Drug Research and Development Co., LtdNCT06470191 A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.Primary Membranous Nephropathyrecruiting216
2026-12-31 est.P3Kartos Therapeutics, Inc.NCT06479135 Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to RuxolitinibMyelofibrosis; Post-PV MF; Post-ET Myelofibrosis; Primary Myelofibrosis; MFrecruiting600
2026-12-31 est.P1/P2Xenothera SASNCT06495723 Polyspecific Antibodies in Lymphoproliferative T-cell DisordersPeripheral T Cells Lymphoma (PTCL)recruiting54
2026-12-31 est.P3NaviFUS CorporationNCT06496971 A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) UGlioblastoma Multiforme; Glioblastoma; Glioblastoma Multiforme, Adult; Glioma; Brain Tumor; Brain Turecruiting32
2026-12-31 est.P1/P2Spirovant Sciences, Inc.NCT06526923 A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)Cystic Fibrosisrecruiting15
2026-12-31 est.P3Boehringer IngelheimNCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Kidney Disease, Chronicactive not recruiting8371
2026-12-31 est.P1/P2Excyte Biopharma LtdNCT06580301 Study of YK012 in B-cell Acute Lymphoblastic LeukemiaB-cell Acute Lymphoblastic Leukemiarecruiting46
2026-12-31 est.P3Longboard PharmaceuticalsNCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)Dravet Syndromeactive not recruiting108
2026-12-31 est.P3Corza Medical GmbHNCT06664775 A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During SurgeryHemorrhagerecruiting116
2026-12-31 est.P2Tasly Pharmaceutical Group Co., LtdNCT06669169 Efficacy and Safety of Jia Shen Tablets in Chronic Heart FailureHeart Failurenot yet recruiting288
2026-12-31 est.P2Jazz Pharmaceuticals JAZZNCT06695845 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsBreast Cancer; Gastric Cancer; Esophageal Cancer; Gastroesophageal Cancer; Colorectal Cancer; Endomerecruiting200
2026-12-31 est.P3Tasly Pharmaceutical Group Co., LtdNCT06696261 A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress SyndromePostprandial Distress Syndromerecruiting342
2026-12-31 est.P1/P2Hangzhou Hanx Biopharmaceuticals, Ltd.NCT06703255 A Phase 2 Study of HX301 in Patients with High-grade GilomaGliomarecruiting72
2026-12-31 est.P2Beijing Biostar Pharmaceuticals Co., Ltd.NCT06730581 Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsGastric Cancer Adenocarcinoma Metastatic; Ovarian Cancer; Bile Duct Cancernot yet recruiting100
2026-12-31 est.P2Shanghai Henlius BiotechNCT06769152 A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant TumorsCervical Cancer; Ovarian Cancerrecruiting190
2026-12-31 est.P1/P2Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT06770881 JSKN033 in Chinese Subjects with Advanced Malignant TumorsAdvanced Malignant Tumorsnot yet recruiting430
2026-12-31 est.P2ShionogiNCT06776432 Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep ApneaSleep Apneaactive not recruiting60
2026-12-31 est.P2Innovent Biologics (Suzhou) Co. Ltd.NCT06797297 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic MucosalMelanomaactive not recruiting203
2026-12-31 est.P1/P2Evopoint Biosciences Inc.NCT06799637 Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard TreatmentsAdvanced Solid Tumors; Pancreatic Carcinoma; Ovarian Cancer; Cervical Cancersrecruiting350
2026-12-31 est.P2Ono Pharmaceutical Co., Ltd.NCT06803823 A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease DementiaAgitation Associated With Alzheimer's Disease Dementiarecruiting90
2026-12-31 est.P3Biocity Biopharmaceutics Co., Ltd.NCT06819826 A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with ProteinuriaIgA Nephropathy (IgAN)recruiting360
2026-12-31 est.P2Valenta Pharm JSCNCT06842966 Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary DyskinesiaChronic Cholecystitis; Biliary Dyskinesiarecruiting300
2026-12-31 est.P2Valenta Pharm JSCNCT06843018 Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious aPharyngitis Acute; Pharyngitis; Nasopharyngitis; Exacerbation of Chronic Pharyngitisrecruiting300
2026-12-31 est.P3Laboratorios Silanes S.A. de C.V.NCT06863701 Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout ArthritisGout Arthritis; Gout Attackrecruiting72
2026-12-31 est.P3Innovent Biologics (Suzhou) Co. Ltd.NCT06884293 A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Overweight; Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)active not recruiting479
2026-12-31 est.P3Hangzhou Highlightll Pharmaceutical Co., LtdNCT06887127 A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid ArthritisRheumatoid Arthritisactive not recruiting350
2026-12-31 est.P2Innovent Biologics Technology Limited (Shanghai R&D Center)NCT06908876 A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema(DME)Diabetic Macular Oedemaactive not recruiting150
2026-12-31 est.P2Blueprint Medicines CorporationNCT06931405 Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)Chronic Inducible Urticaria; Chronic Spontaneous Urticariaactive not recruiting105
2026-12-31 est.P1/P2Jacobio Pharmaceuticals Co., Ltd.NCT06959615 A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene AlterationAdvanced Solid Tumorrecruiting334
2026-12-31 est.P3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06961201 Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the CacheExtensive-stage Small Cell Lung Cancer (ES-SCLC); The Pre-cachexia or Cachexia Patients Who Have Notnot yet recruiting94
2026-12-31 est.P3Clarity Pharmaceuticals LtdNCT06970847 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate CancerProstate Cancer; Prostate Cancer Patients With Detectable PSA Following Prostatectomy; Prostate Cancactive not recruiting220
2026-12-31 est.P3GeneCradle IncNCT06971094 Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - PhasSMA - Spinal Muscular Atrophyactive not recruiting50
2026-12-31 est.P2Hillhurst Biopharmaceuticals, Inc.NCT07005180 Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's DiseaseParkinson Diseaserecruiting36
2026-12-31 est.P2EL3 Bio, LLC.NCT07010926 A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's DiseaseCrohn&Amp;#39;s; Crohn&Amp;#39;s Disease (CD)not yet recruiting120
2026-12-31 est.P2Shenyang Sunshine Pharmaceutical Co., LTD.NCT07022002 SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid TumorsLocally Advanced, Recurrent or Metastatic Malignanciesrecruiting340
2026-12-31 est.P2Imbioray (Hangzhou) Biomedicine Co., Ltd.NCT07087158 A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell CarcinomaRenal Cell Carcinoma (RCC)recruiting30
2026-12-31 est.P3Innovent Biologics (Suzhou) Co. Ltd.NCT07113262 A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye DiseaseThyroid Eye Diseaserecruiting111
2026-12-31 est.P2Shanghai Synvida Biotechnology Co.,Ltd.NCT07121413 A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis(IPF)recruiting48
2026-12-31 est.P2ScinnoHub Pharmaceutical Co., Ltd.NCT07127042 Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty(TKA)Total Knee Arthroplastyrecruiting270
2026-12-31 est.P3VivaVision Biotech, IncNCT07136805 A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior UveitisNon-infectious Anterior Uveitisactive not recruiting154
2026-12-31 est.P1/P2Shanghai Cell Therapy Group Co.,LtdNCT07146672 Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for TumorsSolid Tumor Cancerrecruiting12
2026-12-31 est.P3Qilu Pharmaceutical Co., Ltd.NCT07162883 Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small-Cell Lungactive not recruiting146
2026-12-31 est.P1/P2Mapi Pharma Ltd.NCT07185815 Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for TreatmenSchizophrenia; Bipolar I Disorder; Major Depressive Disorderrecruiting24
2026-12-31 est.P3Galderma R&DNCT07186413 A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne VulgarisAcne Vulgarisactive not recruiting561
2026-12-31 est.P3HK inno.N CorporationNCT07192263 Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes MellitusObesity &Amp; Overweightnot yet recruiting300
2026-12-31 est.P2Elixiron Immunotherapeutics (Hong Kong) Ltd.NCT07223229 Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo PatientsNon-segmental Vitiligorecruiting45
2026-12-31 est.P2Supernus Pharmaceuticals, Inc. SUPNNCT07226661 Double-blind, Placebo-controlled Study in Adults With Major Depressive DisorderMajor Depressive Disorder (MDD)recruiting230
2026-12-31 est.P3RemeGen Co., Ltd.NCT07249632 A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)Myasthenia Gravis, Ocularrecruiting120
2026-12-31 est.P2Ostia SciencesNCT07256743 Efficacy of SALI-10 Oral Probiotics in Experimental GingivitisGingivitisactive not recruiting60
2026-12-31 est.P1/P2Tasly Pharmaceutical Group Co., LtdNCT07265349 A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart FailureCoronary Artery Bypass Grafting (CABG); Chronic Heart Failure; Chronic Ischemic Cardiomyopathyrecruiting51
2026-12-31 est.P1/P2TheiaNova Ltd.NCT07388069 Study of TN-001 Topical Eyedrops for KeratoconusKeratoconusenrolling by invitation20
2026-12-31 est.P2Initiator PharmaNCT07391241 A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)Vulvodyniaactive not recruiting24
2026-12-31 est.P2Innovent Biologics (Suzhou) Co. Ltd.NCT07402070 IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung CancerResectable Stage II-III Non-small Cell Lung Cancernot yet recruiting10
2026-12-31 est.P1/P2Beijing Tuohua Weiye Biotechnology Co., Ltd.NCT07413549 Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B CirrhosisDecompensated Hepatitis B Cirrhosisrecruiting76
2026-12-31 est.P2Tarsus Pharmaceuticals, Inc. TARSNCT07443202 Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)Ocular Rosaceaenrolling by invitation155
2026-12-31 est.P2Sinotau Pharmaceutical GroupNCT07443696 PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic CardiomyopathyIschemic Cardiomyopathy; Heart Failurerecruiting40
2026-12-31 est.P2/P3Tasly Pharmaceutical Group Co., LtdNCT07485595 A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe DepressionDepressionnot yet recruiting180
2026-12-31 est.P2Sano Chemicals IncNCT07521137 Biweekly Long-term Occidiofungin Study for Suppression of Mycotic RecurrenceCandidiasis, Vulvovaginalrecruiting36
2026-12-31 est.P1/P2Shanghai RAAS Blood Products Co., Ltd.NCT07644832 An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) CharacteristicsHemophilia A; Hemophilia B; Factor VII Deficiencyrecruiting76
2026-12-31 est.P2E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.NCT07712523 A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY201 Tablets in SubjAdult Subjects With Non-Segmental Vitiligorecruiting200
2026-12-31 est.P2Guangdong Hengrui Pharmaceutical Co., LtdNCT07719530 Phase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisPsoriasisrecruiting60
2026-12-31 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT07746726 Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in AdultsNeuromuscular Blockaderecruiting320
2026-12-31 est.P2Innovent Biologics (Suzhou) Co. Ltd.NCT07764861 A Open-Label Phase in Participants With Multiple MyelomaMultiple Myelomanot yet recruiting120
2026-12-31 est.P3PT Bio FarmaNCT07824310 Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in ChildrenHuman Papillomavirus (HPV) Infectionnot yet recruiting266
2026-12-31 est.P2Hexin (Suzhou) Pharmaceutical Technology Co., LtdNCT07920835 A Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT ImagingSoft Tissue Sarcomarecruiting60

← 2026-11 | 2027-01 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.